Patterns of Drug-Induced Liver Injury Among Patients Receiving First-Line Anti- Tuberculosis Therapy at a National Referral Centre in Sri Lanka: A Prospective Observational Study
Year: 2026
Type: preprint
Study design: Observational Study
Abstract: Background Drug-induced liver injury (DILI) represents a significant complication of anti-tuberculosis therapy (ATT). There is limited evidence on its biochemical patterns and clinical outcomes in Sri Lanka. This study aimed to characterise the biochemical patterns, clinical features, and outcomes of ATT-associated DILI. Methods A prospective observational study was conducted at the National Hospital for Respiratory Diseases, Welisara, Sri Lanka, from January to June 2026. Adults who developed DILI while receiving first-line ATT were consecutively recruited and prospectively followed. Biochemical injury patterns were classified using the R-ratio calculated from alanine aminotransferase and alkaline phosphatase measurements obtained at initial DILI diagnosis. Clinical characteristics, treatment modifications and outcomes were analysed. Results Forty-six patients were included (mean age 58.7 ± 14.8 years; 71.7% male). Mixed-pattern injury was most prevalent (60.9%), followed by hepatocellular (26.1%) and cholestatic (13.0%) patterns. The most frequently reported symptoms were nausea (89.1%), vomiting (69.6%), and fatigue (67.4%). Jaundice was observed in 15.2% of patients and occurred significantly more often in those with cholestatic injury (p = 0.026). No statistically significant associations were found between biochemical patterns and demographic or clinical characteristics. Modification of ATT was necessary in 73.9% of cases, and 93.5% underwent drug rechallenge. Full recovery was achieved in 65.2% of patients, partial recovery in 28.3%, and mortality was 4.3%. Conclusions Mixed-pattern liver injury predominated in this prospective Sri Lankan cohort, in contrast to the hepatocellular predominance reported in several international studies. ATT-associated DILI frequently required treatment modification, illustrating the importance of early recognition, biochemical monitoring and careful drug reintroduction.
Source: Research Square
Language: English
Subfield: Pharmacology
Domain: Life Sciences
Open Access status: green
OpenAlex ID: W7230039907
